Traducción en proceso. Mostrando versión en inglés.

Bain, UBS Lend $382 Million to Quadrant’s Aidacare in Australia

ArchivadoFuente Única|1 artículos|1 fuentes|1 bloques

Detectado: Actualizado: Analizado:

Finanzas Salud

Hechos Reportados

Datos observables compartidos por todas las narrativas

•Bain Capital and UBS have lent a combined $382 million to Aidacare.
•Aidacare is a portfolio company of Quadrant Private Equity in Australia.
•The loan was announced on February 18, 2026.

Qué Podría Pasar Si...

▸If Aidacare uses the loan to expand its healthcare services Aidacare's market share in the Australian healthcare sector could increase, benefiting Quadrant Private Equity's portfolio.

Inicia sesión para ver todos los escenarios y señales.

Exposición de Mercado

AccionesQuadrant Private Equity portfolio companiesPresión Alcista

If the loan enables Aidacare to grow, it could positively impact the valuation of Quadrant's healthcare assets.

Inicia sesión para ver 1 más instrumento

Esto no es asesoramiento de inversión. La exposición de mercado se basa en análisis condicional de eventos.

Actores Clave

Países

🌍Australia

Organizaciones

🏛Aidacare 🏛Bain Capital 🏛Quadrant Private Equity 🏛UBS Group AG

Cobertura por Fuentes

FINANCE

1 artículos

Más cobertura relacionada

Más sobre Australia
Más sobre Aidacare
Más sobre Bain Capital
Más sobre Quadrant Private Equity

Señales

Single-block coverage

Eventos Relacionados

▸Bain Capital Nears Final Close of $10.5B Asia FundArchivado ▸Australia’s Qube agrees to $8.3 billion buyout from Macquarie-led consortiumArchivado ▸Australian Fund Considers Increasing Private Credit InvestmentsArchivado ▸Indian lender Manappuram gets RBI nod for Bain Capital to take joint controlArchivado ▸BNP Paribas Alternatives Unit Capza Raises €1.4 Billion For Fund

Fuentes (1)

FINANCEBloomberg - MarketsBain, UBS Lend $382 Million to Quadrant’s Aidacare in Australia

Bain Capital and UBS have jointly provided a loan totaling $382 million to Aidacare, a company under Quadrant Private Equity in Australia. This financing deal is significant as it supports Aidacare's operations and potential expansion within the Australian healthcare sector. The involvement of major financial institutions like Bain and UBS underscores confidence in Aidacare's business model and the broader healthcare market in Australia. This transaction may also reflect ongoing investment trends in private equity-backed healthcare companies.